InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the full record of transactions filed by Mailling, Ryan. Director active across 1 company, notably Cipher Pharmaceuticals Inc.. Aggregated, 2 filings have been logged. History available since 30 September 2024. The latest transaction was filed on 23 June 2026 (50 - Grant of options). Regulator: SEDI. All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations